USPTO serial 75190773
Reviewed by CopyMark Law Group
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Monksland, Athlone, County Westmeath, IE
Monksland, Athlone, County Westmeath, IE
Monksland, Athlone, County Westmeath, IE
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
MARLA J CHURCH
MARLA J CHURCH ELAN PHARMACEUTICAL RESEARCH CORP1300 GOULD DRGAINESVILLE, GA 30504UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | non-disintegrating tablet formulations designed to control the absorption of highly water soluble drugs sold as an integral component of various oral pharmaceuticals in the nature of antacids, antispasmodics and anti-ulcerants, laxatives, anti-diarrhoeals, colorectal agents, cardiac drugs, drugs for the treatment of disorders of the central nervous system, CNS stimulants, analgesics, antipyretics and anti-inflammatory agents, muscle relaxants, hormonal, enzymal and steroidal preparations, drugs affecting bone metabolism, drugs affecting the genito-urinary system, diuretics and anti-diuretics, anti-infectives, anti-virals and immunological agents, electrolytes, vitamins and anabolic agents, bronchodilators, anti-asthmatics, expectorants, anti-tussives, decongestants, mucolytics and respiratory stimulants, oropharyngeal, aural and ocular preparations, anti-allergic drugs, hypo-sensitizing preparations, local and general anesthetics, oral and transdermal contraceptives, pharmaceutical preparations for the treatment of dermatological disorders, antineoplastic pharmaceutical preparations for inhibiting or preventing the growth and spread of neoplasms or malignant cells, and medical diagnostic reagents for administration in humans | SECTION 8 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 16, 2005 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Oct 13, 1998 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 21, 1998 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 19, 1998 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 21, 1998 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 13, 1998 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 9, 1997 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Aug 1, 1997 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 29, 1997 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 16, 1997 | DOCK | ASSIGNED TO EXAMINER | — |
| May 15, 1997 | DOCK | ASSIGNED TO EXAMINER | — |
| May 13, 1997 | DOCK | ASSIGNED TO EXAMINER | — |